Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Immuron Limited ( (AU:IMC) ).
Immuron Limited has announced a proposed issue of 2,579,760 ordinary fully paid securities, with a proposed issue date of August 1, 2025. This strategic move aims to bolster the company’s financial position, potentially enhancing its market presence and offering new investment opportunities for stakeholders.
More about Immuron Limited
Immuron Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of immune-mediated diseases.
YTD Price Performance: -2.50%
Average Trading Volume: 1,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €11.04M
See more insights into IMC stock on TipRanks’ Stock Analysis page.
